Abstract
There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Current Pharmaceutical Design
Title: Drug Discovery and Design for Complex Diseases through QSAR Computational Methods
Volume: 16 Issue: 24
Author(s): Cristian R. Munteanu, Enrique Fernandez-Blanco, Jose A. Seoane, Pilar Izquierdo-Novo, Jose Angel Rodriguez-Fernandez, Jose Maria Prieto-Gonzalez, Juan R. Rabunal and Alejandro Pazos
Affiliation:
Keywords: Drug design, QSAR, graphs, complex network, complex disease, QSAR Computational Methods, Drug Discovery, biochemical networks, drug-target interactions, protein-protein interaction networks, protein folding kinetics, (QPDRs), physio-chemical properties, Neurology, Cardiology, Oncology, QSAR models, TIs/CIs, information indices, MARCHINSIDE
Abstract: There is a need for the study of complex diseases due to their important impact on our society. One of the solutions involves the theoretical methods which are fast and efficient tools that can lead to the discovery of new active drugs specially designed for these diseases. The Quantitative Structure - Activity Relationship models (QSAR) and the complex network theory become important solutions for screening and designing efficient pharmaceuticals by coding the chemical information of the molecules into molecular descriptors. This review presents the most recent studies on drug discovery and design using QSAR of several complex diseases in the fields of Neurology, Cardiology and Oncology.
Export Options
About this article
Cite this article as:
R. Munteanu Cristian, Fernandez-Blanco Enrique, A. Seoane Jose, Izquierdo-Novo Pilar, Angel Rodriguez-Fernandez Jose, Maria Prieto-Gonzalez Jose, R. Rabunal Juan and Pazos Alejandro, Drug Discovery and Design for Complex Diseases through QSAR Computational Methods, Current Pharmaceutical Design 2010; 16 (24) . https://dx.doi.org/10.2174/138161210792389252
DOI https://dx.doi.org/10.2174/138161210792389252 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Effect of Non-Statin Lipid Lowering and Anti-Obesity Drugs on LDL Subfractions in Patients with Mixed Dyslipidaemia
Current Vascular Pharmacology The Role of Stem Cell Factor and Granulocyte-Colony Stimulating Factor in Treatment of Stroke
Recent Patents on CNS Drug Discovery (Discontinued) Metabolic Syndrome: Sex-Related Cardiovascular Risk and Therapeutic Approach
Current Medicinal Chemistry Metabolic-Inflammatory Changes, and Accelerated Atherosclerosis in HIV Patients: Rationale for Preventative Measures
Current Medicinal Chemistry Angiogenesis as a Therapeutic Target in Arthritis: Lessons from Oncology
Current Pharmaceutical Design Evaluation of Post-Surgical Cognitive Function and Protein Fingerprints in the Cerebro-Spinal Fluid Utilizing Surface-Enhanced Laser Desorption/Ionization Time-of-Flight Mass-Spectrometry (SELDI-TOF MS) After Coronary Artery Bypass Grafting: Review of Proteomic Analytic Tools and Introducing a New Syndrome
Current Medicinal Chemistry Sex Steroid Hormones, Cardiovascular Diseases and The Metabolic Syndrome
Cardiovascular & Hematological Agents in Medicinal Chemistry Diamidine Activity Against Trypanosomes: The State of the Art
Current Molecular Pharmacology Foreword [The Largest Unmet Market: Chronic Diseases of Aging]
Mini-Reviews in Medicinal Chemistry NMR Based Metabolomics: An Exquisite and Facile Method for Evaluating Therapeutic Efficacy and Screening Drug Toxicity
Current Topics in Medicinal Chemistry Malignancy and Radiation-Induced Cardiotoxicity
Cardiovascular & Hematological Disorders-Drug Targets Importance of Pharmacology Knowledge by Dieticians
Current Nutrition & Food Science Marine Products with Anti-Protozoal Activity: A Review
Current Clinical Pharmacology Hypertension, Prehypertension and Blood Pressure Related Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Antioxidant Components of Brassica Vegetables Including Turnip and the Influence of Processing and Storage on their Anti-oxidative Properties
Current Medicinal Chemistry The Heart Metabolism: Pathophysiological Aspects in Ischaemia and Heart Failure
Current Pharmaceutical Design Inhibition of sPLA2-IIA, C-reactive Protein or Complement: New Therapy for Patients with Acute Myocardial Infarction?
Cardiovascular & Hematological Disorders-Drug Targets The Journey of the Non-Vascular Relief for Migraine: From ‘Triptans’ To ‘Ditans’
Current Clinical Pharmacology The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part III: Specific Management and Surgical Aspects
Current Cardiology Reviews Deep Inspiration Breath-hold (DIBH) Technique to Reduce Cardiac Radiation Dose in the Management of Breast Cancer
Current Cancer Therapy Reviews